Cargando…

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?

According to the current guidelines, severe asthma still represents a controversial topic in terms of definition and management. The introduction of novel biological therapies as a treatment option for severe asthmatic patients paved the way to a personalized approach, which aims at matching the app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galeone, Carla, Scelfo, Chiara, Bertolini, Francesca, Caminati, Marco, Ruggiero, Patrizia, Facciolongo, Nicola, Menzella, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016214/ https://www.ncbi.nlm.nih.gov/pubmed/29992143 http://dx.doi.org/10.1155/2018/4617565

Ejemplares similares

Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
por: Facciolongo, Nicola, et al.
Publicado: (2022)

Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021)

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
por: Menzella, Francesco, et al.
Publicado: (2021)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
por: Menzella, Francesco, et al.
Publicado: (2017)

Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
por: Menzella, Francesco, et al.
Publicado: (2022)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
por: Menzella, Francesco, et al.
Publicado: (2019)

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab
por: Menzella, Francesco, et al.
Publicado: (2019)

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
por: Menzella, Francesco, et al.
Publicado: (2017)

Heat-induced necrosis after bronchial thermoplasty: a new concern?
por: Menzella, Francesco, et al.
Publicado: (2018)

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report
por: Menzella, Francesco, et al.
Publicado: (2018)

Tailored therapy for severe asthma
por: Menzella, Francesco, et al.
Publicado: (2015)

COVID-19: general overview, pharmacological options and ventilatory support strategies
por: Menzella, Francesco, et al.
Publicado: (2020)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Long-term benefits of omalizumab in a patient with severe non-allergic asthma
por: Menzella, Francesco, et al.
Publicado: (2011)

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports
por: Scelfo, Chiara, et al.
Publicado: (2020)

Real-life Efficacy of Omalizumab After 9 Years of Follow-up
por: Menzella, Francesco, et al.
Publicado: (2017)

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
por: Menzella, Francesco, et al.
Publicado: (2015)

Efficacy and safety of EBUS‐TBNA under conscious sedation with meperidine and midazolam
por: Piro, Roberto, et al.
Publicado: (2022)

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report
por: Facciolongo, Nicola, et al.
Publicado: (2015)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

Precision Medicine in Childhood Asthma: Omic Studies of Treatment Response
por: Perez-Garcia, Javier, et al.
Publicado: (2020)

Diagnosis and Pattern Identification of Intrathoracic Malignant Melanoma Metastasis: A Retrospective Single Center Analysis
por: Fontana, Matteo, et al.
Publicado: (2022)

Recent advances in managing idiopathic pulmonary fibrosis
por: Scelfo, Chiara, et al.
Publicado: (2017)

Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020)

Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
por: Benoni, Roberto, et al.
Publicado: (2022)

Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma
por: Facciolongo, N., et al.
Publicado: (2018)

Lung "holes" after cryobiopsy: a case report
por: Piro, Roberto, et al.
Publicado: (2021)

What biomarkers (if any) for precise medicine?
por: Strano, Sabrina, et al.
Publicado: (2015)

Is there any place to corticotropin test in sepsis?
por: Abdellatif, S, et al.
Publicado: (2004)

E-learning any time any place anywhere on mobile devices
por: Eggermont, Sylvia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g8r73c1a8tgubojsnv6fic5sdv